Global InformationIQnovate information
| Company type | Public |
|---|---|
| Industry | Healthcare Services & Facilities |
| Founded | 2011 |
| Headquarters | Sydney, Australia |
Key people | George Syrmalis, CEO |
| Products | Life Sciences Tools and Services |
| Revenue | $1.2 million |
Number of employees | 10 |
| Website | IQnovate |
IQnovate is an Australian life sciences organization that provides intellectual property asset management services and scientific advice to the biopharmaceutical industry.[1][2][3] The company is best known for providing services to government organizations and some of the world's largest biopharmaceutical organizations.[1][3] IQnovate is listed on the National Stock Exchange of Australia under the ticker symbol IQN and on the OTC in New York under the symbol IQNDY.[1][4]
IQnovate is headquartered in Sydney, Australia, and George Syrmalis is the company's current CEO.[1][4]
- ^ a b c d "IQnovate Ltd". OTC Markets. Retrieved 10 May 2013.
- ^ "Innovation and strategies for pharmas, biotechs and the R&D community: IQnovate". BioPharma Australasia Conference. Retrieved 10 May 2013.
- ^ a b "Profile: IQnovate Ltd (IQNDY.PK)". Reuters. Archived from the original on 5 March 2016. Retrieved 10 May 2013.
- ^ a b Bushell-Embling, Dylan. "IQnovate signs first deal since NSX listing". Life Scientist. Retrieved 10 May 2013.